Symptom bothersomeness and life interference support Rome clinical criteria as clinically relevant indicators of DGBI.

MLA

Coitinho Biurra, Yao, et al. “Symptom Bothersomeness and Life Interference Support Rome Clinical Criteria as Clinically Relevant Indicators of DGBI.” Neurogastroenterology & Motility, vol. 36, no. 12, Dec. 2024, pp. 1–10. EBSCOhost, https://doi.org/10.1111/nmo.14936.

APA

Coitinho Biurra, Y., Naude, C., Marchese, S. H., Evans, S., Barber, E., Parigi, E., Cheah, S., Palsson, O., Sperber, A. D., Tack, J., Drossman, D., Mikocka, W. A., & Taft, T. (2024). Symptom bothersomeness and life interference support Rome clinical criteria as clinically relevant indicators of DGBI. Neurogastroenterology & Motility, 36(12), 1–10. https://doi.org/10.1111/nmo.14936

Chicago

Coitinho Biurra, Yao, Colette Naude, Sara H. Marchese, Subhadra Evans, Emily Barber, Elesha Parigi, Suiyin Cheah, et al. 2024. “Symptom Bothersomeness and Life Interference Support Rome Clinical Criteria as Clinically Relevant Indicators of DGBI.” Neurogastroenterology & Motility 36 (12): 1–10. doi:10.1111/nmo.14936.